Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Tetrahydrofuran | HCID 8028 | — |
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | 2-Chloroquinoxaline | HCID 238938 | — |
| Catalyst | Palladium | HCID 23938 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Product | HCID 53729990 | HCID 53729990 | 67% |
Reaction Steps
A 15 mL round bottom flask was charged with (+)-(4aR)-(10bR)-4-methyl-10b-methyl-1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolin-3-one-8-boronic acid (187 mg, 0.65 mmol), tetrakis (triphenylphosphine)palladium(0) (23 mg, 0.02 mmol), 2-chloroquinoxaline (107 mg, 0.65 mmol), 0.65 mL of 2M sodium carbonate solution and 2 mL of THF, fitted with a reflux condenser, and the stirred mixture was heated at 80°, under nitrogen, for 16 h. Added an additional 23 mg of the palladium reagent, and let stir an additional 16 h. The mixture was cooled, diluted with chloroform (75 mL) and washed with brine (2×25 mL). The combined organic extracts were dried over sodium sulfate, concentrated, and purified by silica gel chromatography (ethyl acetate eluent) to give 156 mg (67%) of the title compound as a foam. mp 129°-135°. FDMS: m/e=357. α[D]589 =+72.94 (c=0.63, chloroform).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05670514 |
|---|
| Source dataset | uspto-grants-1997_09 |
|---|
| ORD ID | ord-f43a8b527b1a4136800cc243da54964d |
|---|
| Source note | uspto-grants-1997_09 |
|---|